Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy – (Eye 30, 805 (June 2016))

9 June 2016

This news item is available to RCOphth members only, please log in below to access.